Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Wall Street
Price Targets
Price Targets Summary
Middle East Pharmaceutical Industries Company SJSC
According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 135.66 SAR with a low forecast of 134.33 SAR and a high forecast of 139.65 SAR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Middle East Pharmaceutical Industries Company SJSC's stock price target?
Price Target
135.66
SAR
According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 135.66 SAR with a low forecast of 134.33 SAR and a high forecast of 139.65 SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Revenue forecast?
Projected CAGR
15%
For the last 3 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 11%. The projected CAGR for the next 3 years is 15%.
What is Middle East Pharmaceutical Industries Company SJSC's Operating Income forecast?
Projected CAGR
16%
For the last 3 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is 8%. The projected CAGR for the next 3 years is 16%.
What is Middle East Pharmaceutical Industries Company SJSC's Net Income forecast?
Projected CAGR
17%
For the last 3 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is 6%. The projected CAGR for the next 3 years is 17%.
